From: Outcomes for patients with head and neck squamous cell carcinoma presenting with N3 nodal disease
CRT (n = 20) | RT (n = 8) | Surgery (n = 8) | All (n = 36) | p-value | |
---|---|---|---|---|---|
Age | 0.51 | ||||
Median | 58.5 | 60.5 | 60 | 59 | |
(range) | (43–70) | (44–78) | (48–78) | (43–78) | |
Sex | 0.49 | ||||
Male | 18 (90.0%) | 6 (75.0%) | 6 (75.0%) | 30 (83.3%) | |
Race | 0.86 | ||||
Black | 6 (30.0%) | 3 (37.5%) | 2 (25.0%) | 11 (30.6%) | |
White | 14 (70.0%) | 5 (62.5%) | 6 (75.0%) | 25 (69.4%) | |
p16 | 0.64 | ||||
Negative | 2 (10.0%) | 1 (12.5%) | 2 (25.0%) | 5 (13.9%) | |
Positive | 7 (35.0%) | 1 (12.5%) | 2 (25.0%) | 10 (27.8%) | |
Unknown | 11 (55.0%) | 6 (75.0%) | 4 (50.0%) | 21 (58.3%) | |
Planned neck dissection of N3 neck | 0.27 | ||||
Yes | 11 (55.0%) | 5 (62.5%) | 7 (87.5%) | 23 (63.9%) | |
Tumor Site | 0.42 | ||||
Hypopharynx | 1 (5.0%) | 2 (25.0%) | 1 (12.5%) | 4 (11.1%) | |
Larynx | 3 (15.0%) | 0 (0.0%) | 0 (0.0%) | 3 (8.3%) | |
Oral Cavity | 0 (0.0%) | 0 (0.0%) | 1 (12.5%) | 1 (2.8%) | |
Oropharynx | 14 (70.0%) | 5 (62.5%) | 5 (62.5%) | 24 (66.7%) | |
Unknown | 2 (10.0%) | 1 (12.5%) | 1 (12.5%) | 4 (11.1%) | |
T-Stage | 0.94 | ||||
T0 | 2 (10.0%) | 1 (12.5%) | 1 (12.5%) | 4 (11.1%) | |
T1 | 3 (15.0%) | 2 (25.0%) | 3 (37.5%) | 8 (22.2%) | |
T2 | 5 (25.0%) | 2 (25.0%) | 1 (12.5%) | 8 (22.2%) | |
T3 | 6 (30.0%) | 1 (12.5%) | 0 (0.0%) | 9 (25.0%) | |
T4 | 4 (20.0%) | 2 (25.0%) | 1 (12.5%) | 7 (19.4%) | |
RT Type | < 0.01 | ||||
IMRT | 13 (65.0%) | 0 (0.0%) | 6 (75.0%) | 19 (52.8%) | |
Non-IMRT | 7 (35.0%) | 8 (100.0%) | 2 (25.0%) | 17 (47.2%) | |
Fraction Size | < 0.01 | ||||
Median | 2.11 | 1.67 | 2.0 | 2.0 | |
(range) | (1.4–2.2) | (1.2–2.0) | (1.2–2.1) | (1.2–2.2) | |
RT Total Dose | 0.18 | ||||
Median | 7000 cGy | 7010 cGy | 6800 cGy | 7000 cGy | |
(range) | (6572–7320) | (6700–7460) | (6000–7440) | (6000–7460) | |
Nodal Volume | 0.88 | ||||
Median | 40.3 | 37.8 | 48.8 | 42.7 | |
(range) | (17.3–194.8) | (15.9–81.2) | (23.1–76.0) | (15.9–194.8) |